|
Antisocial Personality Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The men completed the WAI 3 months into their treatment program, while psychopathy was measured via file-based ratings of the Hare's Psychopathy Checklist-Revised (PCL-R), and outcome data were collected via the Canadian Police Information Centre.
|
29294686 |
2020 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Within the TBI group, partial correlations that controlled for age, sex, TSLI, and antianxiety/depression medication use showed that tau concentrations were significantly correlated with greater symptom severity, as measured with the NSI, PCL, and PHQ-9.
|
31033745 |
2020 |
|
Post-Traumatic Stress Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
PTSD Checklist-Civilian Version (PCL-C); Neurobehavioral Symptom Inventory (NSI); Ohio State University TBI Identification Method; Patient Health Questionnaire-9 (PHQ-9); Simoa-measured concentrations of tau, amyloid-beta (Aβ) 40, Aβ42, and neurofilament light (NFL).
|
31033745 |
2020 |
|
Post-Traumatic Stress Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
PTSD and partial PTSD were measured using the PCL-5.
|
31821960 |
2020 |
|
Post-Traumatic Stress Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
PTSD symptoms were measured by the PTSD Checklist for DSM-5 (PCL-5), and the severity (total symptoms) and symptom clusters were calculated according to the hybrid seven-factor model of DSM-5 PTSD.
|
31655035 |
2020 |
|
Post-Traumatic Stress Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Fifty-six patients (71% female, 61% White) with mixed etiology chronic pain completed the PTSD Checklist-Civilian Version (PCL-C) as part of their appointment with a pain psychologist at a tertiary outpatient pain clinic.
|
31646748 |
2020 |
|
Antisocial Personality Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Studies were included if they (1) reported physiological measures of threat response as the primary outcome measure (2) indexed psychopathy using a well-validated clinician rated instrument such as the PCL-R (3) investigated male offenders between 18 and 60 years of age (4) reported threat processing analyses using both Factor 1 and Factor 2 scores (5) provided sufficient data to calculate effect sizes and (6) were published in English-language peer-reviewed journals.
|
31661520 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The modern conception of Psychopathy was introduced by Clerckley in "Mask of Sanity" (1941), and refined by Hare with the construction of the PCL (1980, 1991), a gold standard instrument for the evaluation of the disorder.
|
31488769 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
We examined 62 participants (31 heroin dependent individuals and 31 healthy controls) with the Psychopathy Checklist: Screening version (PCL:SV, Hart et al., 1995) and the Toronto Alexithymia Scale-20 (TAS-20, Bagby et al., 1994).
|
31649591 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
In the current report, psychopathy scores (measured via the Psychopathy Checklist: Youth Version (PCL:YV)) were negatively related to hemodynamic activity within input nuclei of the basal ganglia (i.e., the caudate and nucleus accumbens), as well as intrinsic/output nuclei (i.e., the globus pallidus and substantia nigra) and related nuclei (i.e., the subthalamic nucleus) during error-related processing.
|
31104203 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
The aim of the present study is to consider the underlying factor structure of the PCL:SV (Psychopathy Checklist Screening Version) in a Danish sample as well as considering the role of antisocial behavior in the psychopathy construct.
|
31274196 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
Forensic mental health professionals ranked the 20 Psychopathy Checklist-Revised (PCL-R) items on their importance to psychopathy.
|
30650005 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
To build upon this prior research, the current study used data on male offenders from the Incarcerated Serious and Violent Young Offender Study to examine the network structure of the Comprehensive Assessment of Psychopathic Personality - Institutional Rating Scale (CAPP-IRS; n = 224) and Psychopathy Checklist: Youth Version (PCL:YV; n = 445).
|
30887147 |
2019 |
|
Antisocial Personality Disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
The Psychopathy Checklist: Screening Version (PCL:SV; Hart, Cox, & Hare, 1995) and Borderline Features scale of the Personality Assessment Inventory (PAI; Morey, 1991) were administered at the outset of incarceration.
|
30355022 |
2019 |
|
Cardiovascular Diseases
|
0.100 |
GeneticVariation
|
group |
GWASCAT |
Leveraging Polygenic Functional Enrichment to Improve GWAS Power.
|
30595370 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
All participants were assessed for PTSD using the Chinese PC-PTSD-5 for children and the PTSD Checklist for DSM-5 (PCL-5), and assessed for anxiety using the Chinese version of the State Anxiety Scale for Children (CSAS-C), and for depression using the Children's Depression Inventory - Short Form (CDI-S).
|
31158781 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
<b>Method</b>: Three groups of asylum seekers from different countries (<i>N</i> = 99) completed the Traumatic Grief Inventory Self-Report Version (TGI-SR), Posttraumatic Stress Disorder Checklist-5 (PCL-5), and Patient Health Questionnaire depression module (PHQ-9).
|
30988893 |
2019 |
|
Depressive disorder
|
0.100 |
Biomarker
|
disease |
BEFREE |
PCL-5 scores correlated strongly with scores on measures of depression (ρ = 0.71, <i>p</i> < .001), anxiety (ρ = 0.61, <i>p</i> < .001), and rumination (ρ = 0.68, <i>p</i> < .001), supporting convergent validity.
|
30774783 |
2019 |
|
Depressive disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
In all subjects, the IL-1β levels were correlated with PCL scores, after controlling for covariates, including age, education, marital status and gender, trauma exposure severity and depression.
|
30711869 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
According to characteristics of the tumor microenvironment, in this study, we aimed to synthesize matrix metalloproteinase (MMP)-responsive curcumin (Cur)-loaded nanoparticles (Cur-P-NPs) based on amphiphilic block copolymer (MePEG-peptide-PET-PCL) with MMP-cleavable peptide (GPLGIAGQ) and penetrating peptide (r9), modified to improve tumor targeting and cellular uptake.
|
31691601 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
Compared with free Ara-C, PCL-ss-Ara@Sgc8-BSA significantly enhanced tumor growth inhibition in mice bearing CCRF-CEM xenograft tumors, while causing little side effects, and improved the survival rate of CCRF-CEM tumor-bearing mice in vivo.
|
31769777 |
2019 |
|
Neoplasms
|
0.100 |
Biomarker
|
group |
BEFREE |
HA-PCL-CAP-administered groups presented greater therapeutic efficacy as revealed through reduced tumor volume and improved animal survival rate.
|
30178279 |
2019 |
|
Post-Traumatic Stress Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
At 3 months, PTSD will be defined by a ≥ 33 score at PTSD Check List for DSM-5 (PCL-5) through a telephone interview.
|
31146712 |
2019 |
|
Post-Traumatic Stress Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Study patients were screened for PTSD using the PCL-5 checklist for DSM-5.
|
30878218 |
2019 |
|
Post-Traumatic Stress Disorder
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
Sixty-seven patients with PTSD and 72 patients without PTSD were assessed using the PTSD Checklist for DSM-5 (PCL-5) and psychiatric interview.
|
30579176 |
2019 |